EQUIVAC TAT 1500IU/ML TETANUS ANTITOXIN

Negara: Australia

Bahasa: Inggris

Sumber: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Bahan aktif:

CLOSTRIDIUM TETANI - ANTITOXIN; PHENOL

Tersedia dari:

ZOETIS AUSTRALIA PTY LTD

INN (Nama Internasional):

tetanus antitoxin(1500IU/mL)

Bentuk farmasi:

MISC. VACCINES OR ANTI SERA

Komposisi:

CLOSTRIDIUM TETANI - ANTITOXIN VACCINE-TOXOID Active 1500.0 IU/ml; PHENOL PHENOL Other 2.2 mg/ml

Unit dalam paket:

10mL Vial; 1mL Syr

Kelas:

VM - Veterinary Medicine

Diproduksi oleh:

ZOETIS AUSTRALIA

Kelompok Terapi:

CALF | CATTLE | DOG | GOAT | HORSE | HORSE FOAL | LAMB | PIG - PIGLET | PIGS | SHEEP | BEEF | BEEF CALF | BILLY | BITCH | BOAR |

Area terapi:

IMMUNOTHERAPY

Indikasi Terapi:

TETANUS | TETANUS VACCINATION

Ringkasan produk:

Poison schedule: 0; Withholding period: WHP: Meat:Nil Milk:Nil TRADE ADVICE (AUSTRALIA ONLY): ESI: ESI NOT APPLICAB LE.; Host/pest details: CALF: [TETANUS]; CATTLE: [TETANUS]; DOG: [TETANUS]; GOAT: [TETANUS]; HORSE: [TETANUS]; HORSE FOAL: [TETANUS]; LAMB: [TETANUS]; PIG - PIGLET: [TETANUS]; PIGS: [TETANUS]; SHEEP: [TETANUS]; Poison schedule: 0; Withholding period: ; Host/pest details: CALF: [TETANUS]; CATTLE: [TETANUS]; DOG: [TETANUS]; GOAT: [TETANUS]; HORSE: [TETANUS]; HORSE FOAL: [TETANUS]; LAMB: [TETANUS]; PIG - PIGLET: [TETANUS]; PIGS: [TETANUS]; SHEEP: [TETANUS]; For short term protection and treatment of tetanus in horses, cattle, sheep, goats, pigs and dogs.

Status otorisasi:

Registered

Tanggal Otorisasi:

2023-07-01

Selebaran informasi

AUSTRALIAN GOVERNMENT
AUSTRALIAN PESTICIDES AND
VETERINARY MEDICINES AUTHORITY
APPENDIX 2
TEMPLATE FOR RELEVANT LABEL PARTICULARS (RLPS)
(VETERINARY PRODUCTS)
Select appropriate:
CI New Product (include all applicable RLPs) OR
IZ Variation (highlight instructions that are being varied). Approval
no. of label being varied: 51771/0509.
Signal
heading:
FOR ANIMAL TREATMENT ONLY
Product name:
EQUIVAC
® TAT 1500IU/ML TETANUS ANTITOXIN
Active constituent/s:
Equivac® TAT is prepared by immunising horses against the toxin
produced by
Clostridium tetani.
The immunoglobulin fraction of the hyperimmune serum is separated,
purified and concentrated.
Statement of
claims:
For short term protection and treatment of tetanus in horses, cattle,
sheep, goats, pigs
and dogs.
Net contents:
lmL
dose syringe.
10mL dose vial.
Directions
for Use
Heading:
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT
DIRECTIONS FOR USE
It is strongly advised that Veterinary advice is sought immediately if
tetanus is suspected.
Contents must be left in outer package until immediately before use.
Use all product within 12 hours of opening.
Shake before use.
Before the antitoxin is injected, the proposed site of inoculation on
the animal's skin may
be cleaned by swabbing with cotton-wool soaked in a suitable
antiseptic solution, such as
methylated spirits.
Restraints:
N/A
Contraindications:
N/A
Precautions:
N/A
Side effects:
Allergic reactions such as anaphylaxis occur rarely with biological
products and may
require appropriate treatment. Transient soft tissue swelling
associated with the site of
injection of this product has been reported on rare occasions.
Dosage &
administration:
THE INJECTION IS GIVEN SUBCUTANEOUSLY.
The most convenient site in horses for injection
is the centre of the side of the neck.
DOSAGE
A. FOR PREVENTION OF TETANUS
Horses and Foals
Not less than 1500 Units
,
1*
Adult Cattle
Not less than 1500 Units
RLP
Calves
Not less than 500 Units
Approved
18 Wormald Street, Symonston ACT 2609
PO Box 6182, Kingston ACT 2604 Australia
Tel

Karakteristik produk

PRODUCT NAME: EQUIVAC
™ TAT
PAGE: 1 OF 5
THIS REVISION ISSUED: APRIL, 2010
MATERIAL SAFETY DATA SHEET
Issued by: Pfizer Australia Pty Ltd
Phone: [phone]
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
Pfizer Australia Pty Ltd
38-42 Wharf Road
West Ryde NSW 2114
Tel: [phone]
Fax: [phone]
____________________________________
PFIZER AUSTRALIA PTY LTD
A.B.N. 50 008 422 348
SUBSTANCE:
Tetanus Antitoxin 1500 units/mL
TRADE NAME:
EQUIVAC
® TAT
PFIZER MSDS CODE:
0344
PRODUCT USE:
For the prevention and treatment of tetanus in animals. Injections are
made
subcutaneously or intramuscularly for prevention, and intravenously
for treatment.
CREATION DATE:
AUGUST, 2004
THIS VERSION ISSUED:
APRIL, 2010
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA
Australia.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
Not Hazardous - No criteria found.
SUSDP CLASSIFICATION:
None allocated. (NZ S2)
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good.
UN NUMBER:
None allocated
E
E
E
M
M
M
E
E
E
R
R
R
G
G
G
E
E
E
N
N
N
C
C
C
Y
Y
Y
O
O
O
V
V
V
E
E
E
R
R
R
V
V
V
I
I
I
E
E
E
W
W
W
PHYSICAL DESCRIPTION & COLOUR
: Light straw coloured solution. Presented in a 1mL disposable glass
syringe or a
10mL stoppered and sealed bottle
ODOUR:
No data
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
P
P
P
O
O
O
T
T
T
E
E
E
N
N
N
T
T
T
I
I
I
A
A
A
L
L
L
H
H
H
E
E
E
A
A
A
L
L
L
T
T
T
H
H
H
E
E
E
F
F
F
F
F
F
E
E
E
C
C
C
T
T
T
S
S
S
INHALATION
SHORT TERM EXPOSURE:
Significant inhalation exposure is considered to be unlikely.
Available data indicates that this
product is not harmful. In addition product is unlikely to cause any
discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT: